Mark Taylor is a veteran healthcare journalist who writes for newspapers, online news organizations and healthcare industry business publications. He was a staff reporter for the Gary (Indiana) Post-Tribune and legal affairs reporter for Crain’s Modern Healthcare Magazine. He writes about the business, financing, policy and delivery of healthcare. Taylor is a co-founder of the Association of Health Care Journalists. Taylor lives in Munster, Indiana.
In a study published Tuesday in JAMA, Anthem subsidiary CareMore Health Plan demonstrated how it collaborated with the ride service Lyft to reduce patient waiting times by 30 percent and cut per-ride costs by 32.4 percent.
The consortium will use induced pluripotent stem cell (iPSC) technology — a type of stem cell that can be generated from adult stem cells — to find better treatments for the two psychiatric conditions.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
ClearCare has raised $76 million to date from Battery Ventures, McKesson, Bessemer Venture Partners, Voyager Capital, Cambia Health Solutions and Qualcomm Ventures.
Thar produces an oral version of an existing intravenous drug used to treat the estimated 80,000 Americans diagnosed annually with complex regional pain syndrome.
"This brings us much closer to a ‘lingua franca’ for health information, so clinicians finally have complete information available about their patients.”
Aspect Imaging and design firm frog are working together to develop a new MRI technology that's cheaper and can be placed outside shielded areas in a hospital.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
CVRx, which has struggled to get the FDA nod for an earlier generation device, will use the money to progress its pivotal clinical trial in the U.S. to treat patients with congestive heart failure using neuromodulation.
The collaborative brings together more acronyms than an army battle map, international drug research expertise and as much as $350 million in funding to tackle this looming crisis.
Bruin Biometrics is connecting its wireless pressure ulcer detector, the SEM Scanner, to a digital registry for pressure ulcers known as PUNT (Pressure Ulcer Notification Tool).
Sanford Health, a 43-hospital health system based in Sioux Falls, South Dakota, has contracted with Bellevue, Washington-based Translational Software to provide pharmacogenomics services to its hospitals and nearly 250 clinics in nine states.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
The Fisher Center for Alzheimer's Research Foundation is funding a new technology that allows greater visualization of amyloid plaques as well as other Alzheimer’s markers, such as tau proteins and vasculature and microglia activation.
In another recent member poll, physicians found problems in patient diagnoses gleaned from the Internet.
The bill, known as the ESRD Choice Act (H.R. 5?659), would allow enrollment in the Medicare managed care plans to ESRD patients undergoing dialysis treatment.
“It was driven by the recognition that fundamentally the biological platform for both companies was a mirror image. We both independently uncovered the biology of the immune-microbiome.”
In the revaluation, the onetime Silicon Valley darling allowed large investors to increase their ownership stake in the company in the wake of a scandal.